Eisai
4523.T
#2181
Rank
โ‚น761.99 B
Marketcap
โ‚น2,701
Share price
0.36%
Change (1 day)
8.83%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น77.92. an increase over its 2024 EPS that were of โ‚น87.84.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น98.2511.85%
2024โ‚น87.84-32.63%
2023โ‚น130.395.52%
2022โ‚น123.56-74.01%
2021โ‚น475.38-66.58%
2020โ‚น1,42298.24%
2019โ‚น717.4217.01%
2018โ‚น613.1237.78%
2017โ‚น445.01-27.62%
2016โ‚น614.8435.33%
2015โ‚น454.33-2.82%
2014โ‚น467.53-27.66%
2013โ‚น646.33-27.49%
2012โ‚น891.40-12.67%
2011โ‚น1,02188.08%
2010โ‚น542.73-11.06%
2009โ‚น610.24-390.15%
2008-โ‚น210.32-127.78%
2007โ‚น757.2011.78%
2006โ‚น677.414.38%
2005โ‚น649.027.4%
2004โ‚น604.3243.03%
2003โ‚น422.5325.09%
2002โ‚น337.7752.67%
2001โ‚น221.2469.76%
2000โ‚น130.33